Target Evaluation & Molecular Therapeutics Team
Dr Olivia Rossanese’s team is investigating new targets to support the discovery of novel therapeutics to treat cancer. The team is also defining the molecular and genetic factors governing a cancer’s sensitivity to treatment with new drugs, to guide their clinical use.